Quantcast

Latest Microarrays Stories

2014-02-12 12:25:09

DUBLIN, Feb. 12, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/jcl34v/genomics_market ) has announced the addition of the "Genomics Market by Products and Services - Global Forecast to 2018" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) The global market was valued at $11.11 billion in 2013 and is expected to grow at a CAGR of more than 10.0% during the forecast period. The global genomics products market is...

2014-02-10 08:26:09

--PicoPLEX(TM)Single-Cell Library Preparation Kits for IVF and Other Applications Now Available for Sequencing on Illumina Platforms-- ANN ARBOR, Mich., Feb. 10, 2014 /PRNewswire/ -- Rubicon Genomics, Inc. today announced the launch of its PicoPLEX(TM) DNA-seq Kits for use with Illumina next-generation sequencing (NGS) platforms. PicoPLEX's outstanding robustness and reproducibility have made it the worldwide standard for single-cell DNA amplification for microarray and PCR-based...

2014-02-06 16:32:00

DUBLIN, February 6, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/glj79b/global_next) has announced the addition of the "Global Next Generation Sequencing Market - Forecasts to 2016" [http://www.researchandmarkets.com/research/glj79b/global_next ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) With the expansion of the customer base to less sophisticated customers, access to improved...

2014-02-03 20:22:36

DUBLIN, February 3, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/6cwsz6/molecular) has announced the addition of the "Concise Analysis of the International Molecular Diagnostics in Cancer Testing" [http://www.researchandmarkets.com/research/6cwsz6/molecular ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Molecular diagnostics is a rapidly-advancing area of research and medicine, with...

2014-01-31 23:24:23

OriGene Technologies, Inc. (“OriGene”), one of the industry leaders in producing genome wide products for research and diagnostic applications, has been awarded a contract from the National Cancer Institute (NCI) to develop high affinity anti-peptide antibodies for SISCAPA assays. Rockville, MD (PRWEB) January 31, 2014 Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA), an approach developed by Dr. Leigh Anderson, is a novel technology that can achieve high...

2014-01-17 12:25:14

DUBLIN, January 17, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/zqlcks/biochip_products) has announced the addition of the "2013 Report on the US Biochip Products and Services Market - Trends and Forecast to 2018" [http://www.researchandmarkets.com/research/zqlcks/biochip_products ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The U.S. biochip product market held majority...

2014-01-16 20:22:14

Nicox further expands North American diagnostic portfolio with access to the RetnaGene AMD test, a genetic laboratory-developed test to predict the risk of progressing to late-stage or "wet" age-related macular degeneration (AMD) SOPHIA ANTIPOLIS, France and SAN DIEGO, Jan. 16, 2014 /PRNewswire/ -- Nicox S.A. (NYSE Euronext Paris: COX), and Sequenom, Inc. (NASDAQ:SQNM), today announced that their affiliate companies (Nicox Inc. and Sequenom Laboratories) have entered into an...

2014-01-14 16:26:12

SAN DIEGO, Jan. 14, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, announced today its wholly owned subsidiary, Sequenom Laboratories, entered into an agreement to offer access to its MaterniT21(TM) PLUS laboratory-developed test to Mayo Medical Laboratories. "We are delighted to expand our offerings to our national clients to offer the MaterniT21 PLUS test to physicians who have patients who...

2014-01-12 12:20:22

SAN DIEGO, Jan. 12, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, today announced preliminary highlights of the Company's 2013 performance, accomplishments and outlined key corporate objectives for 2014. Preliminary 2013 Performance Results (unaudited) -- Total revenue of approximately $162 million, showing growth of approximately 81% year-over-year for 2013 -- Diagnostic services...

2014-01-09 16:25:35

SAN DIEGO, Jan, 9, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, announced today its wholly owned subsidiary, Sequenom Laboratories, has signed a national agreement with a leading benefits provider, to provide coverage for the MaterniT21(TM) PLUS laboratory-developed test (LDT). The addition of this contract brings the number of covered lives under agreement by Sequenom Laboratories' diagnostic...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related